Dr Benjamin Lev Solomon, MD | |
1950 Circle Of Hope Dr, Salt Lake City, UT 84112-5500 | |
(801) 581-2121 | |
Not Available |
Full Name | Dr Benjamin Lev Solomon |
---|---|
Gender | Male |
Speciality | Hematology/oncology |
Experience | 11 Years |
Location | 1950 Circle Of Hope Dr, Salt Lake City, Utah |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518209485 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | 9804852-1205 (Utah) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Jordan Valley Medical Center | West jordan, UT | Hospital |
St Johns Medical Center | Jackson, WY | Hospital |
Intermountain Medical Center | Murray, UT | Hospital |
Riverton Hospital | Riverton, UT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Utah Cancer Specialists Pc | 1355254749 | 39 |
News Archive
The allure of shedding unwanted pockets of fat with a series of simple injections, known as mesotherapy, sounds too good to be true - and it just might be. According to an ASPS Device & Technique Assessment (DATA) Committee report published in the April 15 issue of Plastic and Reconstructive Surgery® (PRS), the official medical journal of the American Society of Plastic Surgeons (ASPS), patients should be wary of mesotherapy until the safety and effectiveness of the procedure are confirmed.
Creo Medical Group plc, a medical device company focused on the emerging field of surgical endoscopy, today announces that it has received 510(k) clearance ("FDA Clearance") from the US Food and Drug Administration for its Speedboat RS2 device and the CROMA platform.
A new global study has found that lifestyle risk factors such as alcohol consumption and cigarette smoking are important risk factors for bowel cancer. Researchers have shown that people who consume the largest quantities of alcohol (equivalent to > 7 drinks per week) have 60% greater risk of developing the cancer, compared with non-drinkers.
The need for biosimulation is primarily to do with the very high attrition rate in drug development and especially in the development of drugs for the central nervous system.
› Verified 2 days ago
Entity Name | Utah Cancer Specialists Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1619925369 PECOS PAC ID: 1355254749 Enrollment ID: O20031111000618 |
News Archive
The allure of shedding unwanted pockets of fat with a series of simple injections, known as mesotherapy, sounds too good to be true - and it just might be. According to an ASPS Device & Technique Assessment (DATA) Committee report published in the April 15 issue of Plastic and Reconstructive Surgery® (PRS), the official medical journal of the American Society of Plastic Surgeons (ASPS), patients should be wary of mesotherapy until the safety and effectiveness of the procedure are confirmed.
Creo Medical Group plc, a medical device company focused on the emerging field of surgical endoscopy, today announces that it has received 510(k) clearance ("FDA Clearance") from the US Food and Drug Administration for its Speedboat RS2 device and the CROMA platform.
A new global study has found that lifestyle risk factors such as alcohol consumption and cigarette smoking are important risk factors for bowel cancer. Researchers have shown that people who consume the largest quantities of alcohol (equivalent to > 7 drinks per week) have 60% greater risk of developing the cancer, compared with non-drinkers.
The need for biosimulation is primarily to do with the very high attrition rate in drug development and especially in the development of drugs for the central nervous system.
› Verified 2 days ago
Entity Name | University Of Utah Adult Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1114321981 PECOS PAC ID: 0941525273 Enrollment ID: O20150209001683 |
News Archive
The allure of shedding unwanted pockets of fat with a series of simple injections, known as mesotherapy, sounds too good to be true - and it just might be. According to an ASPS Device & Technique Assessment (DATA) Committee report published in the April 15 issue of Plastic and Reconstructive Surgery® (PRS), the official medical journal of the American Society of Plastic Surgeons (ASPS), patients should be wary of mesotherapy until the safety and effectiveness of the procedure are confirmed.
Creo Medical Group plc, a medical device company focused on the emerging field of surgical endoscopy, today announces that it has received 510(k) clearance ("FDA Clearance") from the US Food and Drug Administration for its Speedboat RS2 device and the CROMA platform.
A new global study has found that lifestyle risk factors such as alcohol consumption and cigarette smoking are important risk factors for bowel cancer. Researchers have shown that people who consume the largest quantities of alcohol (equivalent to > 7 drinks per week) have 60% greater risk of developing the cancer, compared with non-drinkers.
The need for biosimulation is primarily to do with the very high attrition rate in drug development and especially in the development of drugs for the central nervous system.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Benjamin Lev Solomon, MD Po Box 413033, Salt Lake City, UT 84141-3033 Ph: () - | Dr Benjamin Lev Solomon, MD 1950 Circle Of Hope Dr, Salt Lake City, UT 84112-5500 Ph: (801) 581-2121 |
News Archive
The allure of shedding unwanted pockets of fat with a series of simple injections, known as mesotherapy, sounds too good to be true - and it just might be. According to an ASPS Device & Technique Assessment (DATA) Committee report published in the April 15 issue of Plastic and Reconstructive Surgery® (PRS), the official medical journal of the American Society of Plastic Surgeons (ASPS), patients should be wary of mesotherapy until the safety and effectiveness of the procedure are confirmed.
Creo Medical Group plc, a medical device company focused on the emerging field of surgical endoscopy, today announces that it has received 510(k) clearance ("FDA Clearance") from the US Food and Drug Administration for its Speedboat RS2 device and the CROMA platform.
A new global study has found that lifestyle risk factors such as alcohol consumption and cigarette smoking are important risk factors for bowel cancer. Researchers have shown that people who consume the largest quantities of alcohol (equivalent to > 7 drinks per week) have 60% greater risk of developing the cancer, compared with non-drinkers.
The need for biosimulation is primarily to do with the very high attrition rate in drug development and especially in the development of drugs for the central nervous system.
› Verified 2 days ago
Dr. Mehmet Akkaya, M.D Hematology & Oncology Medicare: Medicare Enrolled Practice Location: University Of Utah Hospital Cardiology, 3o N,1900 E, Rm:4a100, Salt Lake City, UT 84132 Phone: 801-505-1689 | |
Dr. Willard Dere, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 500 Foothill Blvd, Salt Lake City, UT 84148 Phone: 801-582-1565 | |
Megan Meier, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121 | |
Joel Money, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121 | |
Mchale O. Anderson, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 4a100, Salt Lake City, UT 84132 Phone: 801-587-2451 | |
Siddharth K. Iyengar, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 4c116, Salt Lake City, UT 84132 Phone: 801-581-7606 | |
Taryn A. Young, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 5121 S Cottonwood St, Salt Lake City, UT 84107 Phone: 801-507-4384 Fax: 801-507-4398 |